Abstract. Cytokine therapy is commonly used for tumor immunotherapy. Although early studies focused directly on the tumor, current investigations are more attentive of the tumor microenvironment. Various immune cells and related cytokines in the tumor microenvironment play an important role in the occurrence and development of tumor. Interleukin (IL)-17 is the characteristic cytokine produced by Th17 cells. IL-17 has been associated with various immune responses. The results of previous studies showed that IL-17 can significantly reduce the size of transplanted tumors in tumor-bearing mice, albeit it has no effect on the survival time of mice. By investigating the effect of IL-17 in the number and distribution of lymphocyte infiltration in tumor tissues, the expression of cytokines and transcription factors associated with the subsets of CD4 + T cells in tumor tissues, the distribution of subsets of spleen lymphocyte in tumor-bearing mice, a preliminary investigation of the possible antitumor mechanism of IL-17 was performed. In conclusion, the antitumor effect of IL-17 gene transfection in the colon cancer of mice may be associated with the mechanisms whereby IL-17 gene transfection can change the distribution of different subsets of spleen lymphocytes in mice. IL-17 gene transfection can increase the number of lymphocyte infiltration in tumor tissues. IL-17 gene transfection can promote the high expression of interferon-γ in tumor tissue, while reducing the expression of IL-10 and IL-13 factors, thus exerting an antitumor effect.
Introduction
Colon cancer is a common malignant tumor of the digestive tract, mostly occurring in the boundary of rectum and sigmoid colon (1, 2) . Clinically, it is more prevalent in males as compared to females. It occurs in the 50-60-year age group, and is the third most prevalent of digestive tract malignant tumors. For many years, the treatment of colon cancer included surgical treatment, chemotherapy and radiotherapy. However, all these methods have some limitations. At present, the biological treatment has become a method of choice secondary to the three conventional treatment methods. It is also one of the most popular research areas. Biological therapy includes many methods such as target therapy, gene therapy and tumor vaccine, of which gene therapy is the most recent research topic (3) . Evidence has shown that the occurrence and development of malignant tumor is closely related to gene alteration (3) . Gene therapy may change the biological behavior of the tumor cells by correcting or repairing the malignant genes.
Cytokines are a class of small molecule proteins with a variety of biological effects. The members of this family play an important role in the occurrence and development of many tumors, therefore cytokine therapy is commonly used for tumor immunotherapy (3, 4) . In previous studies the focus was on the tumor itself, whereas increasingly investigations have focused on the tumor microenvironment. The tumor microenvironment is a comprehensive system composed of tumor cells, endothelial cells, fibroblasts, extracellular matrix, and all types of cells associated with immunity and inflammation (5, 6) . It is the internal environment in which the tumor lies during its occurrence and development (7) . The various immune cells and related cytokines in the tumor microenvironment play an important role in the occurrence and development of tumor.
Interleukin (IL)-17 is the characteristic cytokine produced by Th17 cells. IL-17 is associated with various immune responses (8) . There are varied theories on its mechanism, ranging from the fact that IL-17 can promote tumor metastasis by promoting angiogenesis and enhance the ability of tumor metastasis and invasion in order that IL-17 can inhibit tumor growth by enhancing the immune activity of cytotoxic T cells. The results of our previous studies showed that IL-17 is capable of significantly reducing the size of transplanted tumors in tumor-bearing mice, but has no influence on their survival time. In the present study, a mouse model was established and successfully transfected with IL-17 genes. By investigating the effect of IL-17 in the number and distribution of lymphocyte infiltration in tumor tissues, the expression of cytokines and transcription factors associated with the subsets of CD4 + T cells in tumor tissues, the distribution of subsets of spleen lymphocytes in tumor-bearing mice, a preliminary discussion on the possible antitumor mechanism of IL-17 was conducted, providing sufficient evidence for targeting tumor therapy in the future and providing a new method for tumor therapy.
Materials and methods
Cells and tumor tissues. The cells and tumor tissues used in the present study were all obtained from our previous study (9) . In brief, 60 BALB/c nu/nu mice (4-to 5-week-old male and female mice; n=30 per group) were randomly divided into the control, vector control and experimental groups, n=20 mice per group. C26, C26/pcDNA3.1, and C26/IL-17 cells were injected subcutaneously into the mice of the control group (C26), vector control group (C26/pcDNA3.1) and experimental group (C26/IL-17), respectively. The mice from each group were sacrificed after 5 weeks of the inoculation. The animal experiments were approved by the Animal Experiment and Welfare committee at Hebei Medical University. Tumor tissues were stocked into liquid nitrogen (-196˚C) . The spleen lymphocytes and tumor-infiltrating lymphocytes from each group were obtained using density gradient centrifugation and stocked in liquid nitrogen (-196˚C).
Quantitative polymerase chain reaction (qPCR).
Extracted RNA from tumor tissues and spleen cells was obtained from a previous study (9) . The expression of cytokines and transcription factors associated with T-cell subset differentiation or effect [i.e., interferon (IFN)-γ, IL-4, GATA-3 and retinoid-related orphan receptor (ROR)-γt] were detected. The primer sequence pairs were designed using Primer5 and NCBI online Primer-BLAST software.
The primer sequence pairs used were: β-actin sense: Western blot analysis. Extracted total proteins from tumor tissues were obtained from a previous study (9) . Protein concentrations were determined by Nanodrop ND-1000 (Gene Co., Ltd., Hong Kong, China). Once protein concentrations were determined, 50 µl of the protein specimens were denatured in 50 µl of 2X sample buffer [125 mmol/l Tris-HCl, pH 6.8, 20% glycerol, 10% β-mercaptoethanol, 0.02% bromophenol blue, and 4% sodium dodecyl sulphate (SDS)]. Briefly, 30 µg of denatured protein were separated using SDS-polyacrylamide gel electrophoresis and transferred to a polyvinylidene fluoride membrane, which was blocked in 5% milk proteins that were suspended in tris-buffered saline Tween-20 (TBST) for 2 h at room temperature. The membrane was rinsed three times with TBST, followed by incubation with the primary antibody rabbit anti-mouse IL-17 (polyclonal, bs-1183R) at a 1:500 dilution; rabbit anti-mouse IL-13 (polyclonal, bs-0560R) (both from Beijing Biosynthesis Biotechnology, Beijing, China) at a 1:500 dilution; rabbit anti-mouse IFN-γ (polyclonal, 15365-1-AP) at a 1:500 dilution; rabbit anti-mouse IL-10 (polyclonal, 20850-1-AP) (both from Proteintech, USA) at a 1:500 dilution, rabbit anti-mouse IL-12 (polyclonal, bs-0767R, Beijing Biosynthesis Biotechnology) at a 1:500 dilution; rabbit anti-mouse T-bet (polyclonal, 13700-1-AP) at a 1:200 dilution; rabbit anti-mouse ROR-γt (polyclonal, 13205-1-AP) at a 1:200 dilution; and rabbit anti-mouse Foxp-3 (polyclonal, 22228-1-AP) (all from Proteintech) at a 1:500 dilution overnight at 4˚C. The membrane was then washed and treated with anti-rabbit secondary antibodies (polyclonal, BS13278; Bioworld, China) that were conjugated with horseradish peroxidase at a 1:5,000 dilution. The immuno reactive proteins were visualized with a chemiluminescence detection kit (PerkinElmer, Inc., Waltham, MA, USA), and the expression of glyceraldehyde-3-phosphate dehydrogenase protein was used as the loading control across all the samples analyzed using western blotting.
Hematoxylin and eosin (H&E) staining.
The difference of the number of lymphocyte infiltrations in tumor tissues of mice inoculated with C26/IL-17, C26 and C26/pcDNA3.1 cells was investigated. In a previous study (9) , at 35 days after tumor cell inoculation in mice, the tumor tissues of mice in each group, were fixed in 10% formalin (pH 6.8-7.2) for ≥24 h. Paraffin-embedded blocks were prepared, and 4-µm sections were cut. Sections (4 µm) were dewaxed using xylene and washed with alcohol and water, followed by hematoxylin staining for 5 min. The sections were washed with tap water, differentiated with hydrochloric acid for 30 sec, soaked in tap water for 15 min, and stained with eosin for 2 min. The sections were then dehydrated, cleared and mounted. The difference in the number of lymphocyte infiltrations in tumor tissues was measured. Images of the sections were captured using a Positive electric microscope (U-MCZ, Olympus, Tokyo, Japan) at a high-power field magnification of x400. The number of lymphocytes under a single field of vision were counted. Subsequently, five fields were selected for each section and the average value was calculated.
Statistical analysis. Statistical analysis was performed using SPSS 21.0 software (IBM SPSS, Armonk, NY, USA). Normal distribution test (Kolmogorov-Smirnov test) was used to assess the enumeration data and the one-way ANOVA test was used to evaluate the data with equal variance. The Kruskal-Wallis test was used for data without normal distribution or equal variance. Measurement data were presented as mean ± standard deviation. P<0.05 was considered to indicate a statistically significant difference. The results showed that compared with the mice inoculated with C26 and C26/pcDNA3.1 cells, the spleen lymphocytes of mice inoculated with C26/IL-17 cells had a higher expression of ROR-γt, IFN-γ, IL-4, GATA-3 and IL-10 mRNA (Fig. 1, Table I ) but a lower expression of IL-17, T-bet and Foxp-3 mRNA (P<0.05) (Fig. 2) . Additionally, the expression of mRNA of IL-17, ROR-γt, IFN-γ, T-bet, IL-4, Table I . Expression of cytokines and transcription factors in spleen lymphocytes from different mice (mean ± standard deviation). GATA-3, IL-10 and Foxp-3 in the spleen lymphocyte of mice inoculated with C26 cells and C26/pcDNA3.1 cells had no significant difference (P>0.05).
Results
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Effect of IL-17 gene transfection on lymphocyte infiltration in tumor tissues.
The H&E results showed that the number of lymphocyte infiltration in tumor tissues of mice inoculated with C26/IL-17 cells was significantly more than the other two groups (P<0.05) (Fig. 3 , Table II ). The number of lymphocyte infiltration in tumor tissues of mice inoculated with C26 and C26/pcDNA3.1 cells had no significant difference (P>0.05). The qPCR results showed that, compared with the mice inoculated with C26 and C26/pcDNA3.1 cells, the tumor tissues of mice inoculated with C26/IL-17 cells had a higher expression of IL-17, IFN-γ and IL-23 mRNA, and differences were statistically significant (P<0.05) (Fig. 4, Table III) , whereas a lower expression of IL-4, IL-10, IL-12 and IL-13 mRNA was identified (P<0.05) (Fig. 5) . The mRNA expression of the above cytokines in the tumor tissues of mice inoculated with C26 cells and C26/pcDNA3.1 cells had no significant difference (P>0.05).
Effect of IL-
The western blot results revealed that, compared with the mice inoculated with C26 and C26/pcDNA3.1 cells, the tumor tissues of mice inoculated with C26/IL-17 cells had a higher expression of IL-17, IFN-γ protein ( Table III . Expression of cytokines and transcription factors in tumor tissue from different mice (mean ± standard deviation). the back of mice, and the mice were sacrificed 35 days later. The expression of ROR-γt associated with Th17 cells, T-bet with Th1 cells, GATA-3 with Th2 cells, and Foxp-3 with Treg cells was detected.
Group -----------------------------------------------------------------------------------------------------
The qPCR results showed that compared with the mice inoculated with C26 and C26/pcDNA3.1 cells, the tumor tissues of mice inoculated with C26/IL-17 cells had a higher expression of ROR-γt mRNA (P<0.05) (Fig. 7) but a lower expression of GATA-3 and Foxp-3 mRNA, and differences were statistically significant (P<0.05) (Fig. 8) . The mRNA expression of the above transcription factors in the tumor tissues of mice inoculated with C26 and C26/pcDNA3.1 cells had no significant difference (P>0.05).
The western blotting results showed that, compared with the mice inoculated with C26 and C26/pcDNA3.1 cells, the tumor tissues of mice inoculated with C26/IL-17 cells had a higher expression of ROR-γt protein (Fig. 9) . The expression of ROR-γt protein in the tumor tissues of mice inoculated with C26 and C26/pcDNA3.1 cells had no significant difference (P>0.05).
Discussion
IL-17 is a cytokine with multiple biological effects. It may be produced by NK T cells, CD8 + T cells, γδT cells, dendritic cells, macrophages and other cells (9) , but is mainly produced by Th17 cells (10) . Th17 is a newly identified T-helper cell subset. Its appearance has challenged the traditional classification of CD4 + T-cell subsets. Previous findings have shown that Th17 cell was characterized by secreting cytokine IL-17 (9) . Clinical data have shown that IL-17 was involved in the occurrence of many types of autoimmune diseases and inflammation, and also closely associated with the occurrence and development of tumor. However, its role in tumor is controversial. IL-17 is known to promote tumor by promoting angiogenesis, inhibiting tumor cell apoptosis and promoting tumor metastasis and invasion (11) (12) (13) (14) . By contrast, IL-17 is considered to inhibit tumor by enhancing the activity of NK cells, promoting the activation and production of CTL cells and inhibiting the infiltration of tumor cells (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) .
Radosavljevic et al (25) demonstrated that IL-17 is an important indicator of the development of colon cancer. In a previous study, we successfully established mouse models of colon cancer and identified that IL-17 gene transfection may significantly reduce the tumor size of tumor-bearing mice. This finding may be associated with its antitumor effect. In the current study, we investigated the antitumor mechanism of IL-17 in mice with colon cancer.
It is known that the various subsets of CD4 Tumor microenvironment is an essential internal environment in the development of tumor. It is a comprehensive system composed of tumor cells, endothelial cells, fibroblasts, extracellular matrix, and cells associated with immunity and inflammation (5, 6) . In this complex system, cytokines and various immune cells interact with each other and cooperate to regulate the occurrence, development and invasion and metastasis of tumor. In this study, we conducted an in-depth investigation on the cytokines and Th1, Th2, Th17 and Treg cells in tumor tissues of tumor-bearing mice. Firstly, we applied H&E staining to count the number of infiltrating lymphocytes in tumor tissues. The results showed that IL-17 gene transfection is capable of increasing the number of lymphocytes in the tissues of colon cancer, and the data were statistically significant (P<0.05), indicating that IL-17 gene may exert an antitumor effect by increasing the infiltration of lymphocytes. We also detected the transcription factors associated with Th subsets in the colon cancer tissues and identified that mRNA and proteins of ROR-γt in tumor tissues of mice inoculated with C26/IL-17 cells, were significantly more than the mice inoculated with C26 and C26/pcDNA3.1 cells, and differences were statistically significant (P<0. associated with the plasmid. However, the IL-17 gene further reduced the number of Treg cells. A previous study identified that the role of IL-13 in tumor was the same as IL-10 (26,27). Both were able to promote the tumor growth by inhibiting immunity. The results of our study showed that IL-17 gene transfection can reduce the expression of IL-13 in colon cancer tissues. From the above analysis, we suggest that IL-17 gene exerts an antitumor effect by increasing the expression of IFN-γ and reducing the expression of IL-10 and IL-13.
In conclusion, the antitumor effect of IL-17 gene transfection in the colon cancer of mice may be associated with the following mechanisms: i) IL-17 gene transfection can change the distribution of different subsets of spleen lymphocytes in mice; ii) IL-17 gene transfection can increase the number of lymphocyte infiltration in tumor tissues; and iii) IL-17 gene transfection can promote the high expression of IFN-γ in tumor tissue, while reducing the expression of IL-10 and IL-13 factors, thus exerting an antitumor effect. Overall, we predict that IL-17 directly or indirectly induces the polarization of tumor tissue infiltration lymphocytes and exerts an anti-tumor effect, which requires further investigation.
